Article
FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway
29 Mar 2022
Abstract excerpt
Understanding the regulatory programs enabling cancer stem cells (CSCs) to self-renew and drive tumorigenicity could identify new treatments. Through comparative chromatin-state and gene expression analyses in ovarian CSCs versus non-CSCs, we identified FOXK2 as a highly expressed stemness-specific transcription factor in ovarian cancer. Its genetic depletion diminished stemness features and reduced tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
